GGH
10MG
Lipo-C (FAT BLASTER)is a lipotropic compound blend supplied for lipid metabolism and metabolic activity.
In stock | ≥99% catalog purity
Description
Product specification
Analytical Profile
Catalog data is presented for material identification and laboratory planning. Batch-specific documentation governs the supplied vial.
| RESEARCH NAME | GGH Stack · GHK-Cu + Glutathione + Histidine + Glycine + NADH |
| FORMAT | Multi-component liquid · 10 mL vial |
| COMPOSITION |
GHK-Cu · 2000 mcg Glutathione · 200 mg Histidine · 100 mg Glycine · 50 mg NADH · 50 mg |
| MOLECULAR FORMULA |
GHK-Cu: C14H23CuN6O4+ Glutathione: C10H17N3O6S Histidine: C6H9N3O2 Glycine: C2H5NO2 NADH: C21H29N7O14P2 |
| MOLECULAR MASS |
GHK-Cu: 402.92 g/mol Glutathione: 307.33 g/mol Histidine: 155.15 g/mol Glycine: 75.07 g/mol NADH: 665.4 g/mol |
| CAS REGISTRY |
GHK-Cu: 89030-95-5 Glutathione: 70-18-8 Histidine: 71-00-1 Glycine: 56-40-6 NADH: 58-68-4 |
| ANALYTICAL IDENTITY | Multi-component formulation |
| CATALOG CONDITION | Follow manufacturer storage specification |
PROTOCOL LITERACY
Reconstitution Sequence
This source-derived sequence assumes a 10 mg vial and a final reference volume of 1.0 mL. The supplied product documentation remains the controlling instruction.
01
Prepare
Prepare 1.0 mL of bacteriostatic water with sterile equipment.
02
INTRODUCE SLOWLY
Direct the liquid toward the inside wall of the vial to limit foaming.
03
DISSOLVE GENTLY
Roll or swirl with care until the material is dissolved; do not shake.
04
LABEL AND PROTECT
Record the preparation date and keep the vial protected from light.
05
COLD STORAGE
Refrigerate at 2-8°C and use within the four-week reference window.
UNRECONSTITUTED MATERIAL
-20°C
Keep frozen, dry, sealed, and away from direct light. The supplied source describes stability for up to 24 months.
After reconstitution
2-8°C
Keep refrigerated and light-protected. Avoid repeated temperature cycling and follow batch documentation.
Handling principle
ONE THAW
If an approved study protocol requires frozen aliquots, avoid repeated freeze–thaw cycles.
PROTOCOL LITERACY
CAGRILINTIDE DOSAGE CHART
A designed reference covering concentration, weekly schedule models, reconstitution, supply planning, storage, mechanism, study observations, and administration context. It is educational material—not an individualized regimen.
VIAL CONTENT
1.0 MG
+
REFERENCE DILUENT
1.0 MG
=
STOCK CONCENTRATION
1.0 MG/ML
U-100 SCALE
1 Unit = 0.01 ml 100 mcg
01
GRADUAL 8MG MODEL
02
12 MG TRIAL CONTEXT
EDUCATIONAL REFERENCE
GRADUAL 8MG MODEL
| STUDY INTERVAL | STAGE | WEEKLY DOSE | U-100 REFERENCE | SOLUTION VOLUME |
|---|---|---|---|---|
01
WEEKS 1-4 | INITIATION | 2 MG | 20 UNITS | 0.20 ML |
02
WEEKS 5-8 | ESCALATION 01 | 4 MG | 40 UNITS | 0.40 ML |
03
WEEKS 9-12 | INITIATION | 6 MG | 60 UNITS | 0.60 ML |
04
WEEKS 13+ | UPPER REFERENCE | 8 MG | 80 UNITS | 0.80 ML |
01
REFERENCE ASSUMPTIONS
Every unit and volume value shown assumes a 10 mg vial prepared to a total reference volume of 1.0 mL.
02
MATERIAL BOUNDARY
This table does not provide preparation or administration instructions.
03
PROTOCOL CONTROL
Trial documentation and qualified clinical oversight—not this chart—must govern all dosing decisions.
Related products
-
Melanotan II
View → This product has multiple variants. The options may be chosen on the product page -
GLOW
View → This product has multiple variants. The options may be chosen on the product page -
NAD+
View → This product has multiple variants. The options may be chosen on the product page -
GLUTATHIONE
View → This product has multiple variants. The options may be chosen on the product page -
GHK-Cu
View → This product has multiple variants. The options may be chosen on the product page -
AHK-Cu
View → This product has multiple variants. The options may be chosen on the product page
Product Enquiry
Have a question about this product? Send us your enquiry and our team will get back to you shortly.